Investors

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness’ products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women’s health. Being a leading developer of innovative diagnostic and monitoring devices, allows us to combine near patient monitoring tools with value-added healthcare services in order to improve care and lower healthcare costs for both providers and patients.

Our stock is listed on the New York Stock Exchange under the following symbols:
 

IMA – Common Stock, $.001 par value

IMA.PR.B – Series B Perpetual Convertible Preferred Stock, $.001 par value

For further information please contact Doug Guarino at the following toll free number: 888-872-8679.